As tumor-infiltrating CD8+ T cells are indicators of an active host immune response against cancer [4], we quantified the infiltrating CD8+ T cells in tumor tissues of early- and advanced-stage CRC patients. The gene discussed is CD8A; the disease is colorectal carcinoma.